BioDrain Medical, Inc.·4

Mar 19, 5:18 PM ET

JOHNSON DAVID ORRIN 4

4 · BioDrain Medical, Inc. · Filed Mar 19, 2013

Insider Transaction Report

Form 4
Period: 2013-03-18
JOHNSON DAVID ORRIN
Chief Operating Officer
Transactions
  • Award

    Stock Options (right to buy)

    2013-03-18+949,368949,368 total
    Exercise: $0.08Exp: 2023-03-18Common Stock (949,368 underlying)
Holdings
  • Common Stock

    0
  • Stock Options (right to buy)

    Exercise: $0.08Exp: 2022-08-13Common Stock (1,000,000 underlying)
    1,000,000
Footnotes (2)
  • [F1]700,000 shares vest immediately; 300,000 shares vest on 2/13/2014.
  • [F2]474,684 shares vest on each of 9/18/2013 and 3/18/2014.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -